US and Israel-based medical device company SuperDimension yesterday closed its series B round with $11m of investment from US-based healthcare provider Covidien Ventures, and undisclosed existing investors.

SuperDimension’s last round of funding raised $9.8m, in July 2010, from backers including investment firm OrbiMed Advisors, and venture capital firms Oxford Biosciences Partners, Pitango Venture Capital and Medica Venture Partners.

Alongside the equity funding, SuperDimension also gained a $15m credit facility from the Oxford Finance Corporation in September 2010.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?